David M. Goldstein
Technik-/Wissenschafts-/F&E-Leiter bei PRINCIPIA BIOPHARMA INC.
Aktive Positionen von David M. Goldstein
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PRINCIPIA BIOPHARMA INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 | - |
Frontier Medicines Corp.
 Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | Direktor/Vorstandsmitglied | 30.03.2021 | - |
Karriereverlauf von David M. Goldstein
Ehemalige bekannte Positionen von David M. Goldstein
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ROCHE HOLDING AG | Corporate Officer/Principal | 01.01.1994 | 01.01.2011 |
| Stanford University | Corporate Officer/Principal | - | - |
Ausbildung von David M. Goldstein
| Franklin & Marshall College | Undergraduate Degree |
| University of Virginia | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Schweiz | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- David M. Goldstein
- Erfahrung
